Your Full-Service Accounting + Business Growth Advisory Partner

Tag: Life Sciences

Mandatory Capitalization of R&E Expenses – The Impact on Life Sciences Companies

Life sciences companies engage in considerable, and often exclusively in, research and development activity. Not surprisingly, these companies often face unique challenges relating to R&D — from make-or-build vs. buy decisions, contract research and contract development, and manufacturing arrangements — as they progress through the clinical stages to commercial operations. The R&D landscape for life sciences companies is further complicated by additional challenges brought...

Continue reading

R&D Tax Credits for the Life Sciences Industry

Generate cash from your past and future investments in developing or improving products, formulas or devices, or advancing medical and pharmaceutical technology. In recent years, the Life Sciences industry has been under heavy pressure to drive innovation in an environment of escalating R&D costs, increasing scientific complexity and enhanced regulatory scrutiny. If your company has worked to develop new or improved pharmaceuticals or medical devices, formulas or technology,...

Continue reading


Copyright 2022, Wiss & Company, LLP Accountants & Consultants. All rights reserved.